The market is missing the clues here.
All the CEO interviews and company anns talk about European 2B pivotal trial...but also speak to planning US path forward with FDA?
Then there is talk of other indications.
Hello!
How is a an ASX microcap with $9m cash and handful of staff meant to pursue such grand plans?
Maybe cos the dance has started with BigPharma and we will see a flurry of concurrent Combination trials in EU and US?
Otherwise this aggressive posturing in the company messaging...seemingly approved by the Board...makes no sense.
Not long to go now before we step up to next level at +$100m market cap.
- Forums
- ASX - By Stock
- One Study Away
The market is missing the clues here. All the CEO interviews and...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
Add PER (ASX) to my watchlist
|
|||||
Last
7.0¢ |
Change
-0.001(1.41%) |
Mkt cap ! $63.10M |
Open | High | Low | Value | Volume |
7.1¢ | 7.1¢ | 6.9¢ | $34.01K | 486.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 132919 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.3¢ | 78000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 80000 | 0.069 |
4 | 134427 | 0.068 |
3 | 224490 | 0.067 |
1 | 15000 | 0.066 |
4 | 32000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 78000 | 1 |
0.075 | 13371 | 1 |
0.078 | 75476 | 2 |
0.079 | 175123 | 2 |
0.080 | 287231 | 3 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |